Fibrodysplasia Ossificans Progressiva News and Research

RSS
Research may lead to first-ever pharmacological treatment for rare genetic bone disease

Research may lead to first-ever pharmacological treatment for rare genetic bone disease

Researchers examine critical role of hypoxia in induction, amplification of FOP lesions

Researchers examine critical role of hypoxia in induction, amplification of FOP lesions

Palovarotene drug may prevent multiple musculoskeletal problems linked with FOP

Palovarotene drug may prevent multiple musculoskeletal problems linked with FOP

Clementia expands enrollment to include children with FOP in ongoing Phase 2 clinical trial

Clementia expands enrollment to include children with FOP in ongoing Phase 2 clinical trial

Clementia Pharmaceuticals commences multi-center study of patients with fibrodysplasia ossificans progressiva

Clementia Pharmaceuticals commences multi-center study of patients with fibrodysplasia ossificans progressiva

Clementia's palovarotene receives FDA Fast Track designation for FOP treatment

Clementia's palovarotene receives FDA Fast Track designation for FOP treatment

Clementia gets Orphan Medicinal Product Designation from EMA for palovarotene

Clementia gets Orphan Medicinal Product Designation from EMA for palovarotene

Clementia initiates Phase 2 extension study of palovarotene in FOP patients

Clementia initiates Phase 2 extension study of palovarotene in FOP patients

Genome Project offers new leads to improve outcomes for children with high-grade glioma brain tumors

Genome Project offers new leads to improve outcomes for children with high-grade glioma brain tumors

Researchers use stem cells to study bone disorders from patients afflicted with genetic bone disease

Researchers use stem cells to study bone disorders from patients afflicted with genetic bone disease

Researchers to begin drug development projects for rare and neglected diseases

Researchers to begin drug development projects for rare and neglected diseases

New genetic approach to treat fibrodysplasia ossificans progressiva

New genetic approach to treat fibrodysplasia ossificans progressiva

Research: Substance P appears to trigger formation of extraskeletal bone

Research: Substance P appears to trigger formation of extraskeletal bone

New research reveals potential treatment for HO in children, soldiers

New research reveals potential treatment for HO in children, soldiers

Scientists to develop a treatment for rare genetic disorder, FOP

Scientists to develop a treatment for rare genetic disorder, FOP

Penn researchers discover gene that creates "second skeleton" bone disorder

Penn researchers discover gene that creates "second skeleton" bone disorder

Only 10 percent of doctors have ever heard of fibrodysplasia ossificans progressiva

Only 10 percent of doctors have ever heard of fibrodysplasia ossificans progressiva